Bacterial infections of liver disease

Seminars in Liver Disease

Volumn 17, Issue 4, 1997, Pages 323-333

  Navasa, Miquel ^a   Rimola, Antoni ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFADROXIL; CEFONICID; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PLACEBO; TOBRAMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFICACY; EMPYEMA; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER FAILURE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PARACENTESIS; PRIORITY JOURNAL; REVIEW; SOFT TISSUE INFECTION; SUPERINFECTION; SURVIVAL; TUBERCULOSIS; URINARY TRACT INFECTION;

EID: 0030658020     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007209     Document Type: Review

References (84)

1. Rimola A. Infections in liver disease, in McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodés J (eds) Oxford Textbook of Clinical Hepatology. Oxford, Oxford Medical Press, 1991, pp 1272-1284.
2. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18:353-358, 1993.
3. Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: A variant of spontaneous bacterial peritonitis. Hepatology 4: 1209-1211, 1984.
4. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21:792-796, 1994.
5. Rimola A, Arroyo V, Rodes J. Infective complications in acute and chronic liver failure: Basis and control, in Williams R (ed): Clinics in Critical Care Medicine: Liver Failure. Edinburgh, Churchill-Livingstone. 1986, pp 93-111.
6. Rolando N, Gimson A, Philpott-Howard J, et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: Role of antibiotic prophylaxis. J Hepatol 18:290-294, 1993.
7. Selby WS, Norton ID, Pokorny CS, et al. Bacteremia and bacteriascitis after esophageal varices and prevention by intravenous cefotaxime: A randomized trial. Gastrointest Endosc 40:680-684, 1994
8. Toyoda K, Saku YU, Sadoshima S, et al. Purulent meningitis after endoscopic injection sclerotherapy for esophageal varices. Intern Med 33:706-709, 1994.
9. Bac DJ, de Marie S, Siersema PD, et al. Post-sclerotherapy bacterial peritonitis: A complication of sclerotherapy or of variceal bleeding? Am J Gastroenterol 89:859-862, 1994.
10. Arroyo V, Gines P, Planas R. Treatment of ascites in cirrhosis-Diuretics, peritoneovenous shunt and large-volume paracentesis Gastroenterol Clin North Am 21:237-256, 1992.
11. Gines A, Planas R, Angeli P, et al. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis. Hepalology 22:124-131, 1995.
12. Casafont Morencos F, de las Heras Castaño G, Martín Ramos L, et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 40:1252-1256, 1995.
13. Sorell WT, Quigley EMM, Jin G, et al. Bacterial translocation in the portal-hypertensive rat: Studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 104: 1722-1726, 1993.
14. Llovet JM, Bartoli R, Planas R, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis Gut 35:1648-1652, 1994.
15. Garcia-Tsao G, Lee FY, Barden GE, et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108.1835-1841, 1995.
16. Van Leeuwen PAM, Boermeester MA, Houdijk AP, et al. Clinical significance of translocation. Gut 35(suppl 1):S28-S34, 1994.
17. Llovet JM, Bartoli R, Planas R, et al Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 23:781-787, 1996.
18. Jones EA, Summerfield JA. Kupffer cells, in Arias IM, Jakoby WB, Popper H, Schacter D, Shafritz DA (eds): The Liver: Biology and Pathobiology, ed 2. New York, Raven Press, 1988, pp 683-704.
19. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 53-58, 1984.
20. Bolognesi M, Merkel C, Bianco S, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19:628-634, 1994.
21. Guarner C, Runyon BA. Macrophage function in cirrhosis and the risk of bacterial infection. Hepatology 22:367-369, 1995.
22. Gomez F, Ruiz P, Schreiber AD Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 331:1122-1128, 1994.
23. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8:632-635, 1988.
24. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 91:1343-1346, 1986.
25. Tito LI, Rimola A, Gines P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors. Hepatology 8:27-31, 1988.
26. Llach J, Rimola A, Navasa M,et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration. Hepatology 16:724-727, 1992.
27. Andreu M, Solá R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis. Gastroenterology 104:1133-1138, 1993.
28. Runyon BA, Antillon MR, McHutchmson JG. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. J Hepatol 14:249-252, 1992
29. Garcia-Gonzalez M, Boixeda D, Herrero D, et al. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 105:527-531, 1993.
30. Navasa M. Treatment of spontaneous bacterial peritonitis and other severe bacterial infections in the setting of cirrhosis, in Arroyo V, Bosch J, Rodes J (eds): Treatments in Hepatology. Barcelona, Masson, 1995, pp 109-115.
31. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5:457-462, 1985.
32. Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100:1737-1742, 1991.
33. Rimola A, Salmeron JM, Clemente G, et al Two different dosages of cefotaximc in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study. Hepatology 21:674-679, 1995.
34. Ariza J, Xiol X, Esteve M, et al. Aztreonam vs cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients Hepatology 14:91-98, 1991.
35. Mercader J, Gómez J, Ruiz J, et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 35(suppl 2):23-26, 1989.
36. Gómez-Jimenez J, Ribera E, Gasser I, et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother 37:1587-1592, 1993.
37. Grange JD, Amiot X, Grange V, et al. Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: A prospective study of twenty-seven cases in cirrhotic patients. Hepatology 11:360-364, 1990.
38. Silvain C, Breux JP, Grollier G, et al. Les septicémies et les infections du liquide d'ascite du cirrhotique peuvent-elles être traitées exclusivement par voie orale? Gastroenterol Clin Biol 13:335-339, 1989.
39. Navasa M, Folio A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111:1011-1017, 1996.
40. García-Tsao G. Treatment of spontaneous bacterial peritonitis with oral ofloxacin. inpatient or outpatient therapy? Gastroenterology 111:1147-1150, 1996.
41. Toledo C, Salmerón JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime Hepatology 17:251-257, 1993.
42. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis Hepatology 20: 1495-1501, 1994.
43. Byl B, Roucloux I, Crusiaux A, et al. Tumor necrosis factor alpha and interleukin-6 plasma levels in infected cirrhotic patients. Gastroenterology 104:1492-1497, 1993.
44. Zeni F, Tardy B, Vindimian M, et al. High levels of tumor necrosis factor alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 17:218-223, 1993.
45. Propst T, Propst A, Herold M, et al. Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its. secondary mediators in ascitic fluid. Eur J Clin Invest 23 832-836, 1993.
46. Rimola A, Bory F, Terés J, et al. Oral non-absorbable antibiotics prevent infection in cirrhosis with gastrointestinal hemorrhage Hepatology 5:463-467, 1985.
47. Soriano G, Guarner C, Tomás A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103:1267-1272, 1992.
48. Blaise M, Pateron D, Trinchet J-C, et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 20:34-38, 1994.
49. Soriano G, Guarner C, Teixidó M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100:477-481, 1991.
50. Ginès P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial Hepatology 12:716-724, 1990.
51. Dupeyron C, Mangeney N, Scdrati L, et al. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 38:340-344, 1994.
52. Llovet JM, Rodríguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol 26:88-95, 1997.
53. Rolanchon A, Cordier L, Bacq Y, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis. Results of a prospective controlled trial. Hepatology 22:1171-1174, 1995.
54. Singh N, Gayowski T, Yu VL, et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial. Ann Intern Med 122: 595-598, 1995.
55. Rabinivitz M, Prieto M, Gavaler JS, et al. Bacteriuria in patients with cirrhosis. J Hepatol 16:73-76, 1992.
56. Burroughs AK, Rosenstein IJ, Epstein O, et al. Bacteriuria and primary biliary cirrhosis. Gut 25:133-137, 1984
57. Lipsky BA Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis and treatment. Ann Intern Med 110:138-150, 1989.
58. Westphal J-F, Jehl F, Vetter D Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver Clin Infect Dis 18:324-335, 1994.
59. Adams HG, Jordan C. Infections in the alcoholic. Med Clin North Am 68:179-200, 1984
60. Bradsher RW. Overwhelming pneumonia. Med Clin North Am 67 1233-1250, 1983.
61. Levy M, Dromer F, Brion N, et al. Community-acquired pneumonia. Chest 92:43-48, 1988.
62. Craven DE, Daschner F, Guiot L. Current topic: Nosocomial pneumonia. Eur J Clin Infect Dis 8:1-75, 1989.
63. Torres A, Celis R. Neumonías intrahospitalarias. Med Clin (Barcelona) 88:34-37, 1987.
64. Panés J, Terés J, Bosch J, et al. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive patients. Dig Dis Sci 33:454-459, 1988
65. Hudolin V. Tuberculosis and alcoholism. Ann NY Acad Sci 252:353-364, 1975.
66. Burack WR, Hollister RM. Tuberculous peritonitis: A study of forty-seven proved cases encountered by a general medical unit in twenty-five years. Am J Med 28:510-523, 1960.
67. Borhanmanesh F, Hekmat K, Vaezzadeh K, et al. Tuberculous peritonitis: Prospective study of thirty-two cases in Iran. Ann Intern Med 76:567-572, 1986.
68. Dineen P, Homan WP, Grafe WR. Tuberculous peritonitis: 43 years' experience in diagnosis and treatment. Ann Surg 184: 717-722, 1976.
69. Palmer KR, Patil DH, Basran GS, et al. Abdominal tuberculosis in urban Britain: A common disease. Gut 26:1296-1305, 1985.
70. Aguado JM, Pons F, Casafont F, et al Tuberculous peritonitis: A study comparing cirrhotic and noncirrhotic patients. J Clin Gastroenterol 12:550-554, 1990.
71. Cellier C, Landi B, Mesnard B, et al. Clinical, laparoscopic and histological features in 71 patients with tuberculous peritonitis. Eur J Gastroenterol Hepatol 6:831-834, 1994.
72. Martinez-Vazquez JM, Ocaña I, Ribera E, et al. Adenosine deaminase activity in the diagnosis of tuberculous peritonitis. Gut 27:1049-1053, 1986.
73. Rodriguez de Lope C, San Miguel G, Pons F. Laparoscopic diagnosis of tuberculous ascites. Endoscopy 14:178-179, 1982.
74. Dutt AK, Moers D, Stead WW. Short-course chemotherapy for extrapulmonary tuberculosis. Ann Intern Med 104:7-12, 1986
75. Swartz MN. Cellulitis and subcutaneous tissue infections, in Mandel GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 4. Edinburgh, Churchill-Livingstone, 1995, pp 909-928.
76. Snyder N, Atterbury CE, Correia JP, et al. Increased occurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. Gastroenterology 73:1107-1113, 1977.
77. Denton JH, Rubio C, Velázquez J, et al. Bacterial endocarditis in cirrhosis Dig Dis Sci 26:935-937, 1981.
78. Flaum MA. Spontaneous bacterial empyema in cirrhosis. Gastroenterology 70:416-417, 1976.
79. Xiol X, Castellví JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: A prospective study. Hepatology 23:719-723, 1996.
80. Larcher VF, Wyke RJ, Mowat AL, et al. Bacterial and fungal infection in children with fulminant hepatic failure: Possible role of opsonization and complement deficiency. Gut 23:1037-1043, 1982.
81. Kasravi FB, Wang L, Wang XD, et al. Bacterial translocation in acute liver injury induced by D-galactosamine. Hepatology 23: 97-103, 1996.
82. Salmeron JM, Tito L, Rimola A, et al. Selective intestinal decontamination in the prevention of bacterial infections in patients with acute liver failure. J Hepatol 14:280-285, 1992.
83. Rolando N, Gimson A, Wade J, et al. Prospective controlled trial of selective parenteral and enterai antimicrobial regimen in fulminant hepatic failure. Hepatology 17:196-201, 1993
84. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 345:163-169, 1995.